Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-30

Clinical Trial Update: Tailored Treatments of Fibromyalgia [Phase 2, Phase 3]

View source ↗

Summary

The University of Washington conducted Phase 2 and Phase 3 trials of tailored treatments for fibromyalgia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Washington | Conditions: Fibromyalgia | Phase 2, Phase 3 | Status: COMPLETED